57 related articles for article (PubMed ID: 15876163)
1. Is the resistance of large conduit arteries also decreased in thyrotoxic patients with Graves' disease?
Czarkowski M; Hilgertner L; Powałowski T; Radomski D; Mikulska M
Thyroid; 2005 Apr; 15(4):377-81. PubMed ID: 15876163
[TBL] [Abstract][Full Text] [Related]
2. [Mean arterial blood flow depends on the intensity of thyrotoxicosis in patients with Graves' disease].
Czarkowski M; Hilgertner L; Powałowski T; Radomski D
Pol Merkur Lekarski; 2005 Jun; 18(108):667-70. PubMed ID: 16124380
[TBL] [Abstract][Full Text] [Related]
3. The stiffness of the common carotid artery in patients with Graves' disease.
Czarkowski M; Hilgertner L; Powałowski T; Radomski D
Int Angiol; 2002 Jun; 21(2):152-7. PubMed ID: 12110776
[TBL] [Abstract][Full Text] [Related]
4. Serum ratio of triiodothyronine to thyroxine, and thyroxine-binding globulin and calcitonin concentrations in Graves' disease and destruction-induced thyrotoxicosis.
Amino N; Yabu Y; Miki T; Morimoto S; Kumahara Y; Mori H; Iwatani Y; Nishi K; Nakatani K; Miyai K
J Clin Endocrinol Metab; 1981 Jul; 53(1):113-6. PubMed ID: 6165731
[TBL] [Abstract][Full Text] [Related]
5. Interplay Between Thyroid Hormone Status and Pulmonary Hypertension in Graves' Disease: Relevance of the Assessment in Thyrotoxic and Euthyroid Patients.
Araruna LVM; de Oliveira DC; Pereira MC; Moura Neto A; Tambascia MA; Zantut-Wittmann DE
Front Endocrinol (Lausanne); 2021; 12():780397. PubMed ID: 35069439
[TBL] [Abstract][Full Text] [Related]
6. Thyroid-stimulating antibody is related to Graves' ophthalmopathy, but thyrotropin-binding inhibitor immunoglobulin is related to hyperthyroidism in patients with Graves' disease.
Noh JY; Hamada N; Inoue Y; Abe Y; Ito K; Ito K
Thyroid; 2000 Sep; 10(9):809-13. PubMed ID: 11041459
[TBL] [Abstract][Full Text] [Related]
7. Benefit of short-term iodide supplementation to antithyroid drug treatment of thyrotoxicosis due to Graves' disease.
Takata K; Amino N; Kubota S; Sasaki I; Nishihara E; Kudo T; Ito M; Fukata S; Miyauchi A
Clin Endocrinol (Oxf); 2010 Jun; 72(6):845-50. PubMed ID: 19912243
[TBL] [Abstract][Full Text] [Related]
8. Decrease of immunoglobulin G-Fc receptor-bearing T lymphocytes in Graves' disease.
Mori H; Amino N; Iwatani Y; Asari S; Izumiguchi Y; Kumahara Y; Miyai K
J Clin Endocrinol Metab; 1982 Sep; 55(3):399-402. PubMed ID: 6178751
[TBL] [Abstract][Full Text] [Related]
9. Persistent increase in bone turnover in Graves' patients with subclinical hyperthyroidism.
Kumeda Y; Inaba M; Tahara H; Kurioka Y; Ishikawa T; Morii H; Nishizawa Y
J Clin Endocrinol Metab; 2000 Nov; 85(11):4157-61. PubMed ID: 11095447
[TBL] [Abstract][Full Text] [Related]
10. Plasma free triiodothyronine response to thyrotropin-releasing hormone to predict the remission of Graves' disease treated with antithyroid drugs.
Notsu K; Oka N; Masaki Y; Furuya H; Kato Y
J Clin Endocrinol Metab; 1991 Aug; 73(2):396-400. PubMed ID: 1713218
[TBL] [Abstract][Full Text] [Related]
11. Serum cytokines levels in Graves' disease.
Al-Humaidi MA
Saudi Med J; 2000 Jul; 21(7):639-44. PubMed ID: 11500727
[TBL] [Abstract][Full Text] [Related]
12. Lower serum free thyroxine (T4) levels in painless thyroiditis compared with Graves' disease despite similar serum total T4 levels.
Shigemasa C; Abe K; Taniguchi S; Mitani Y; Ueda Y; Adachi T; Urabe K; Tanaka T; Yoshida A; Mashiba H
J Clin Endocrinol Metab; 1987 Aug; 65(2):359-63. PubMed ID: 3110204
[TBL] [Abstract][Full Text] [Related]
13. Effect of thyrotropin-releasing hormone on serum thyroid hormones: a study in the patients with untreated and treated Graves' disease and subacute thyroiditis.
Sato A; Yamada T; Aizawa T; Ichikawa K; Komiya I; Takasu N; Takemura Y
J Clin Endocrinol Metab; 1995 Jul; 80(7):2173-7. PubMed ID: 7608274
[TBL] [Abstract][Full Text] [Related]
14. Short and long term effects of radioiodine and antithyroid drugs on T4 binding proteins, free T4 and T3, during Graves' disease therapy.
Jaffiol C; Baldet L; Robin M; Papachristou C; Lapinski H; Mirouze J
Horm Metab Res; 1977 Jan; 9(1):73-81. PubMed ID: 66177
[TBL] [Abstract][Full Text] [Related]
15. Thyroidal triiodothyronine and thyroxine in Graves' disease: correlation with presurgical treatment, thyroid status, and iodine content.
Larsen PR
J Clin Endocrinol Metab; 1975 Dec; 41(06):1098-104. PubMed ID: 54364
[TBL] [Abstract][Full Text] [Related]
16. The effect of combination therapy with propylthiouracil and cholestyramine in the treatment of Graves' hyperthyroidism.
Tsai WC; Pei D; Wang TF; Wu DA; Li JC; Wei CL; Lee CH; Chen SP; Kuo SW
Clin Endocrinol (Oxf); 2005 May; 62(5):521-4. PubMed ID: 15853819
[TBL] [Abstract][Full Text] [Related]
17. Increased stiffness in common carotid artery in hyperthyroid Graves' disease patients.
Inaba M; Henmi Y; Kumeda Y; Ueda M; Nagata M; Emoto M; Ishikawa T; Ishimura E; Nishizawa Y
Biomed Pharmacother; 2002 Jul; 56(5):241-6. PubMed ID: 12199623
[TBL] [Abstract][Full Text] [Related]
18. Aggravation of thyrotoxicosis in early pregnancy and after delivery in Graves' disease.
Amino N; Tanizawa O; Mori H; Iwatani Y; Yamada T; Kurachi K; Kumahara Y; Miyai K
J Clin Endocrinol Metab; 1982 Jul; 55(1):108-12. PubMed ID: 6896207
[TBL] [Abstract][Full Text] [Related]
19. Graves' hyperthyroidism and moderate alcohol consumption: evidence for disease prevention.
Carlé A; Bülow Pedersen I; Knudsen N; Perrild H; Ovesen L; Rasmussen LB; Jørgensen T; Laurberg P
Clin Endocrinol (Oxf); 2013 Jul; 79(1):111-9. PubMed ID: 23170908
[TBL] [Abstract][Full Text] [Related]
20. Treatment with lithium prevents serum thyroid hormone increase after thionamide withdrawal and radioiodine therapy in patients with Graves' disease.
Bogazzi F; Bartalena L; Campomori A; Brogioni S; Traino C; De Martino F; Rossi G; Lippi F; Pinchera A; Martino E
J Clin Endocrinol Metab; 2002 Oct; 87(10):4490-5. PubMed ID: 12364424
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]